Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation

NCT01149993 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped FDA clinical hold, IND withdrawn.

Conditions

Kidney Transplantation
Renal Transplantation
Reperfusion Injury

Interventions

DRUG: Myfortic (mycophenolic acid)
DRUG: Myfortic (mycophenolic acid)
DRUG: Thymoglobulin (anti-thymocyte globulin)
DRUG: Thymoglobulin (anti-thymocyte globulin)

Sponsor

Georgetown University

Collaborators

[object Object]